according to medicalnewstoday
Stem cell therapy restores arm, hand movement for paralyzed man
Stem cell therapy restores arm, hand movement for paralyzed man
A 21-year-old man left paralyzed after a spinal cord injury has regained the use of his arms and hands, thanks to an experimental stem cell treatment performed by researchers from the Keck Medical Center at the University of Southern California.Researchers have restored arm and hand function to a paralyzed man with injections of an agent called AST-OPC1.Researchers have restored arm and hand function to a paralyzed man with injections of an agent called AST-OPC1.
by the same token on eurekalert
CAR-T cell therapy makes strides in clinic *free*
CAR-T cell therapy makes strides in clinic *free*
In a phase 1 clinical study of 32 participants with advanced B cell non-Hodgkin lymphoma, immunotherapy with defined subsets of T cells, rather than whole T cell populations, showed strong antitumor activity.The findings suggest that pinning down a few key variables - the optimal T cell combinations, dosage, and pretreatment chemotherapy regimen - is critical to unlocking the full potential of chimeric antigen receptor (CAR)-modified T cell therapies, an approach that reprograms T cells with artificial receptors designed to target tumor cells.While the therapy is moving toward the clinic at a rapid pace, inconsistencies in CAR-T cell compositions pose a major hurdle.
moreover from cancerresearchuk
Extra chemo boosts immune cell therapy in lymphoma
Extra chemo boosts immune cell therapy in lymphoma
Using two chemotherapy drugs instead of one may boost the effectiveness of a type of immune cell therapy, according to a new US study."This is important because it will help guide the design of future trials using these specialised T cells" - Professor John Anderson, Cancer Research UK.The early clinical trial showed better responses and improved short-term survival in patients with non Hodgkin lymphoma given the combined treatments.
No comments:
Post a Comment